Chemoinformaics analysis of 1-beta-hydroxy-2-oxopomolic acid
Molecular Weight | 502.692 | nRot | 1 |
Heavy Atom Molecular Weight | 456.324 | nRig | 28 |
Exact Molecular Weight | 502.329 | nRing | 5 |
Solubility: LogS | -3.75 | nHRing | 0 |
Solubility: LogP | 3.522 | No. of Aliphatic Rings | 5 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 85.5845 |
nHD | 4 | BPOL | 47.8835 |
QED | 0.396 |
Synth | 5.274 |
Natural Product Likeliness | 3.065 |
NR-PPAR-gamma | 0.714 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.008 |
Pgp-sub | 0.001 |
HIA | 0.04 |
CACO-2 | -5.595 |
MDCK | 0.0000175 |
BBB | 0.969 |
PPB | 0.9266 |
VDSS | 0.529 |
FU | 0.1057 |
CYP1A2-inh | 0.003 |
CYP1A2-sub | 0.509 |
CYP2c19-inh | 0.006 |
CYP2c19-sub | 0.814 |
CYP2c9-inh | 0.062 |
CYP2c9-sub | 0.652 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.106 |
CYP3a4-inh | 0.142 |
CYP3a4-sub | 0.19 |
CL | 2.019 |
T12 | 0.112 |
hERG | 0.002 |
Ames | 0.015 |
ROA | 0.574 |
SkinSen | 0.016 |
Carcinogencity | 0.019 |
EI | 0.03 |
Respiratory | 0.975 |
NR-Aromatase | 0.885 |
Antiviral | Yes |
Prediction | 0.654476 |